Fetuin A in Hashimoto Thyroiditis

Completed

• Conditions: Hashimoto Thyroiditis

• Registration Number: NCT01884649
• Lead Sponsor: Istanbul Medeniyet University

Brief Summary

Fetuin-A levels are reported to be low as a negative acute phase reactant in systemical inflammatory situations. Hashimoto thyroiditis is characterized with inflammation. In this study, we hypothesised that the serum fetuin A levels could be found to be low due to inflammation in patients with Hashimoto thyroiditis

Detailed Description

Patients ≥ 20 years of age being followed up at the outpatient clinics of the Internal Medicine Department in Medeniyet University Goztepe Training and Research Hospital and fulfilling the eligibility criteria will be included in the study. Approval of the local ethics committee and informed consent of the participants will be received for the study. The study is conducted in accordance with the Declaration of Helsinki. Demographic characteristics, concomitant diseases, smoking and alcohol drinking habits, concomitant medication usage, anthropometric and biochemistry data of the eligible patients will be recorded. Patient group will consist of patients with newly diagnosed Hashimoto thyroiditis and the control group will consist of healthy volunteers.

Groups will be compared according to their demographic, an¬thropometric and biochemistry data and serum fetuin-A levels. In order to detect the relationship between the serum fetuin-A levels and clinical features, correlation analyses will be done.

Study Timeline

• Study Start: 2012-05
• Primary Completion: 2012-10
• Study Completion: 2012-10
• Status Verified: 2013-06
• Study First Submitted: 2013-06-17
• Study First Submitted QC: 2013-06-21
• Last Update Submitted: 2013-06-21
• Study First Posted: 2013-06-24
• Last Update Posted: 2013-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 97

Inclusion Criteria

• patients newly diagnosed with Hashimoto thyroiditis

Exclusion Criteria

• Acute infection
• Acute or chronic inflammatory disease
• Anti-inflammatory treatment (non-steroidal anti-inflammatory, corticosteroids etc.)
• Hypoxic situations (chronic obstructive pulmonary disease etc.)
• Severe heart, kidney and liver disease
• Pregnancy
• Endocrine disorders
• Malignancy
• Usage of drug that affects thyroid hormone levels

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison of serum fetuin A levels between patients with Hashimoto thyroiditis and healthy subjects	1 day (The blood samples were obtained on the same day participants arrived to outpatient clinics.)